DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Blepharitis - Pipeline Review, H2 2016" drug pipelines to their offering.
'Blepharitis - Pipeline Review, H2 2016'; Blepharitis pipeline therapeutics constitutes close to 8 molecules. Out of which approximately 8 molecules are developed by Companies.
Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin, blockage of the eyelid's oil glands, and occasionally allergies. Blepharitis signs and symptoms include watery eyes, red eyes, itchy eyelids, sensitivity to light. Treatment includes antibiotics, lubricating eye drops and steroid eye drops or ointments.
'Blepharitis - Pipeline Review, H2 2016' outlays comprehensive information on the therapeutics under development for Blepharitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
It also reviews of key players involved in therapeutic development for Blepharitis and features dormant and discontinued projects. Currently, The molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 3, 2, 1 and 2 respectively.
Key Topics Covered:
- Introduction
- Blepharitis Overview
- Therapeutics Development
- Pipeline Products for Blepharitis - Overview
- Pipeline Products for Blepharitis - Comparative Analysis
- Blepharitis - Therapeutics under Development by Companies
- Blepharitis - Therapeutics under Investigation by Universities/Institutes
- Blepharitis Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Blepharitis - Products under Development by Companies
- Blepharitis - Products under Investigation by Universities/Institutes
- Blepharitis - Companies Involved in Therapeutics Development
- Allergan Plc
- InSite Vision Incorporated
- Kala Pharmaceuticals, Inc.
- NicOx S.A.
- Quorum Innovations LLC
- Senju Pharmaceutical Co., Ltd.
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/btb9ms/blepharitis
Related Topics: Optical
